AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer

Preliminary finding of stable disease in two out of three patients at 6 months in the first subject cohort Combination of Ampligen and Imfinzi continues to be generally well-tolerated with no severe adverse events or dose-limiting toxicities OCALA, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) today announced positive […]

IT Nation Introduces New IT Nation Torch Award Program for 2024 Flagship Event

TAMPA, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) — IT Nation, a global community of peers, thought leaders, and experts dedicated to elevating the IT ecosystem to new heights, has announced its new award program, the IT Nation Torch Awards, which will debut at this year’s IT Nation Connect event taking place from November 6-8, 2024,

Humacyte Announces Allowance of U.S. Patent Covering BioVascular Pancreas (BVP(TM))

– New U.S. patent covers the design and composition of the BVP – – Positive results from ongoing preclinical studies support the potential of the BVP to deliver insulin-producing islets as a potential treatment for type 1 diabetes – DURHAM, N.C., Sept. 19, 2024 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform

Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)

–Participant baseline characteristics in INFRONT-3 suggest a representative study population that enables testing of the effects of latozinemab in frontotemporal dementia with a progranulin gene mutation (FTD-GRN)– –Latozinemab, a novel investigational human monoclonal antibody, is the most advanced PGRN-elevating candidate in development for the treatment of FTD-GRN– SOUTH SAN FRANCISCO, Calif., Sept. 19, 2024 (GLOBE

Condor Receives a Second Feed Gas Allocation for Its LNG Projects in Kazakhstan

CALGARY, Alberta, Sept. 19, 2024 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX: CDR), a Canadian based energy transition company is pleased to announce that it has received its second natural gas allocation (“Gas Allocation”) from the Kazakhstan State authority responsible for gas distribution. The Gas Allocation will be used as feed

Red Cat Holdings to Report Fiscal First Quarter 2025 Financial Results and Provide Corporate Update on Monday, September 23, 2024

SAN JUAN, Puerto Rico, Sept. 19, 2024 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, announces that financial results for the fiscal first quarter 2025 (3 months ended July 31, 2024) will be reported

Gold Bull defines two new drill targets at Sandman High grade rock chip samples up to 210g/t Ag & 1.11g/t Au

VANCOUVER, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) — Gold Bull Resources Corp. (TSX-V: GBRC) (“Gold Bull” or the “Company“) is pleased to report results of ongoing exploration targeting field work completed at its Sandman project, located in Nevada, USA. New silver target emerges at K8 Prospect New prospect and drill target defined at “Abel

HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health

NAPLES, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) — via IBN – HealthLynked Corp. (OTCQB: HLYK), a leader in healthcare technology, is proud to announce its integration with Lyric Health, a comprehensive virtual care provider. This partnership enables HealthLynked to expand its telehealth services nationwide, offering patients in all 50 states convenient access to healthcare anytime,

Asbestos Contamination in Everyday Talc Fuels Alarm and Health Concerns Among U.S. Women

AUSTIN, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) — A new national survey of U.S. women shows alarming levels of asbestos risk from everyday consumer talc-based products, highlighting the need for regular gynecological tests to help with early detection of asbestos-related cancers such as mesothelioma. Commissioned by asbestos awareness advocacy firm AsbestosClaims.law, a division of The

Aeroflow Health Launches Venture Arm; Co-Leads $3.7 Million Seed Round for Canopie

ASHEVILLE, N.C., Sept. 19, 2024 (GLOBE NEWSWIRE) — Aeroflow Health, a pioneering healthcare company that leverages cutting-edge technology to support the delivery of medical products and services, today announced the launch of its venture capital arm, Aeroflow Ventures, to invest in health tech solutions that increase access to care and improve quality of life. Aeroflow

Scroll to Top